Oncotelic Therapeutics, Inc. (OTLC) Insider Trading

Name: Oncotelic Therapeutics, Inc. (OTLC) insider trading: SEC Form 4 filings
Creator: Insiders Notifier
License: https://www.sec.gov/privacy#dissemination

Latest Form 4 (Jul 23, 2026): Fein Seymour Howard (CRO/CMO): Grant/Award of 250 shares.

Get alerted when insiders trade OTLC

Email address

Loading company data...

Beta

Loading company details...

Beta